HC Wainwright Has Negative Outlook of CADL FY2025 Earnings
Candel Therapeutics, Inc. (NASDAQ:CADL – Free Report) – Stock analysts at HC Wainwright decreased their FY2025 earnings estimates for Candel Therapeutics in a research report issued to clients and investors on Wednesday, February 26th. HC Wainwright analyst V. Bernardino now forecasts that the company will post earnings of ($1.39) per share for the year, down […]
Candel Therapeutics, Inc. (NASDAQ:CADL – Free Report) – Stock analysts at HC Wainwright decreased their FY2025 earnings estimates for Candel Therapeutics in a research report issued to clients and investors on Wednesday, February 26th. HC Wainwright analyst V. Bernardino now forecasts that the company will post earnings of ($1.39) per share for the year, down […]
